F. Mosquera-rekin lankidetzan egindako argitalpenak (31)

2014

  1. Affective dimensions as a diagnostic tool for bipolar disorder in first psychotic episodes

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 29, Núm. 7, pp. 424-430

  2. Mapa geográfico de salud mental: variación geográfica en psicosis y asociación con factores ambientales : proyecto de investigación comisionada, noviembre 2014

    Servicio Central de Publicaciones = Argitalpen Zerbitzu Nagusia

2013

  1. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis

    BMC Psychiatry, Vol. 13

  2. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 44, pp. 29-33

2010

  1. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

    International Clinical Psychopharmacology, Vol. 25, Núm. 4, pp. 241-245

  2. Insight, psychosis and aggressive behaviour in mania

    European Journal of Psychiatry, Vol. 24, Núm. 2, pp. 70-77

  3. Insight, psychosis and aggressive behaviour in mania

    European journal of psychiatry, Vol. 24, Núm. 2, pp. 70-77

  4. Long-term efficacy of a psychological intervention program for patients with refractory bipolar disorder: A pilot study

    Psychiatry Research, Vol. 176, Núm. 2-3, pp. 161-165

  5. Manic and depressive symptoms and insight in first episode psychosis

    Psychiatry Research, Vol. 178, Núm. 3, pp. 480-486

2009

  1. Implicaciones clínicas de la edad de inicio del trastorno bipolar I: dos subgrupos con diferente pronóstico

    Revista de Psiquiatria y Salud Mental, Vol. 2, Núm. 1, pp. 29-34

  2. Validity and reliability of the Hamilton Depression Rating Scale (5 items) for manic and mixed bipolar disorders

    Journal of Nervous and Mental Disease, Vol. 197, Núm. 9, pp. 682-686

2008

  1. Attitudes of patients and family members towards implantable psychiatric medication

    Schizophrenia Research, Vol. 105, Núm. 1-3, pp. 279-286

  2. Impact of cannabis and other drugs on age at onset of psychosis

    Journal of Clinical Psychiatry, Vol. 69, Núm. 8, pp. 1210-1216

2007

  1. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder

    Schizophrenia Research, Vol. 95, Núm. 1-3, pp. 174-178

  2. Epidemiology, diagnosis and management of mixed mania

    CNS Drugs, Vol. 21, Núm. 8, pp. 611-626

  3. Predictors of suicide in first-episode affective and nonaffective psychotic inpatients: Five-year follow-up of patients from a catchment area in Vitoria, Spain

    Journal of Clinical Psychiatry, Vol. 68, Núm. 2, pp. 242-247

2006

  1. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients

    Schizophrenia Research

  2. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment

    Bipolar Disorders, Vol. 8, Núm. 5 II, pp. 618-624

2004

  1. Dimensions of mania: Differences between mixed and pure episodes

    European Psychiatry, Vol. 19, Núm. 5, pp. 307-310

  2. Psychoeducation and cognitive-behavioral therapy in bipolar disorder: An update

    Acta Psychiatrica Scandinavica, Vol. 109, Núm. 2, pp. 83-90